Skip to content

Safety of Non-restricted potassium diet in patients with end-stage renal disease on maintenance dialysis

Safety of Non-restricted potassium diet in patients with end-stage renal disease on maintenance dialysis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064070
Enrollment
Unknown
Registered
2022-09-25
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Interventions

Intervention Group:Potassium Non-restricted Diet

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1: Patients with end-stage kidney disease receiving maintenance hemodialysis (thrice per week) for over 3 months 2: Aged >=18 yrs and <=70 yrs 3: Urine output <400ml per day 4: Ability to act independently and cooperate with study measures

Exclusion criteria

Exclusion criteria: 1: Inability to take study diets due to gastrointestinal diseases or other reasons 2: Patients with diabetes 3: Patients with constipation or diarrhea 4: Patients who have developed unexplained hyperkalemia or have developed hyperkalemia of a known cause within one month prior to the study but of which cause has not been corrected 5: Patients using Potassium-containing supplements (e.g., low-sodium salts) or medications containing potassium salts 6: Patients who had received blood transfusion within one month prior to enrollment or who may require blood transfusion during the study period 7: Atrioventricular block Second degree or above 8: Need for hospitalization due to acute infection, acute phase of cardiovascular and cerebrovascular events, or any other causes within two weeks before enrollment 9: Any other scenario in which researchers do not consider it appropriate for the subject to participate in the study

Design outcomes

Primary

MeasureTime frame
Hyperkalemia;plasma potassium;

Secondary

MeasureTime frame
Quality of life;

Countries

China

Contacts

Public ContactWenjin

Northern Jiangsu People's Hospital

liuwj1989@hotmail.com18262638696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026